Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €78.00 Price Target at Independent Research

Independent Research set a €78.00 ($90.70) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note published on Monday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Other equities analysts have also recently issued reports about the company. Kepler Capital Markets set a €70.00 ($81.40) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Thursday, February 20th. Goldman Sachs Group set a €80.00 ($93.02) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Thursday, February 20th. Bank of America set a €85.00 ($98.84) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Friday, November 1st. Sanford C. Bernstein set a €73.00 ($84.88) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Tuesday, November 12th. Finally, Jefferies Financial Group set a €80.00 ($93.02) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Thursday, February 20th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have given a buy rating to the company. The stock currently has a consensus rating of Buy and an average price target of €80.82 ($93.98).

FME opened at €72.50 ($84.30) on Monday. The stock has a 50-day moving average price of €70.74 and a 200-day moving average price of €65.00. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €57.24 ($66.56) and a 12-month high of €81.10 ($94.30). The company has a current ratio of 1.02, a quick ratio of 0.73 and a debt-to-equity ratio of 104.49. The stock has a market capitalization of $22.06 billion and a P/E ratio of 18.31.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Recommended Story: Why do analysts give a neutral rating?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.